Tesamorelin is a 44–amino acid synthetic analogue of growth hormone–releasing hormone (GHRH) studied for its ability to stimulate natural growth hormone production. Research highlights its potential to reduce visceral fat—particularly in HIV-associated lipodystrophy—by up to 20%, support peripheral nerve health, slow cognitive decline, and improve metabolic function.